Ana María Bajo Chueca-rekin lankidetzan egindako argitalpenak (26)

2024

  1. Antagonist of Growth Hormone-Releasing Hormone Receptor MIA-690 Suppresses the Growth of Androgen-Independent Prostate Cancers

    International Journal of Molecular Sciences, Vol. 25, Núm. 20

  2. GHRH and the prostate

    Reviews in Endocrine and Metabolic Disorders

  3. Induction of more aggressive tumoral phenotypes in LNCaP and PC3 cells by serum exosomes from prostate cancer patients.

    e-cienciaDatos

2023

  1. Carbohydrate effect of novel arene Ru(II) phenanthroline-glycoconjugates on metastatic biological processes

    Journal of Inorganic Biochemistry, Vol. 247

  2. Induction of more aggressive tumoral phenotypes in LNCaP and PC3 cells by serum exosomes from prostate cancer patients

    International Journal of Cancer, Vol. 153, Núm. 10, pp. 1829-1841

2022

  1. Tumorigenic transformation of human prostatic epithelial cell line RWPE-1 by growth hormone-releasing hormone (GHRH)

    Prostate, Vol. 82, Núm. 8, pp. 933-941

2020

  1. Stimulation of neuroendocrine differentiation in prostate cancer cells by GHRH and its blockade by GHRH antagonists

    Investigational New Drugs, Vol. 38, Núm. 3, pp. 746-754

2019

  1. In vitro and in vivo evaluation of first-generation carbosilane arene Ru(II)-metallodendrimers in advanced prostate cancer

    European Polymer Journal, Vol. 113, pp. 229-235

  2. Water soluble, optically active monofunctional Pd(II) and Pt(II) compounds: Promising adhesive and antimigratory effects on human prostate PC-3 cancer cells

    Dalton Transactions, Vol. 48, Núm. 38, pp. 14279-14293

2018

  1. Biological evaluation of water soluble arene Ru(II) enantiomers with amino-oxime ligands

    Journal of Inorganic Biochemistry, Vol. 183, pp. 32-42

  2. Experiencias de aprendizaje y evaluación colaborativa gamificada mediante iTest

    Educación y compromiso social [Recurso electrónico]: Aprendizaje Servicio (ApS) y otras metodologías

  3. Growth hormone-releasing hormone receptor antagonists modify molecular machinery in the progression of prostate cancer

    Prostate, Vol. 78, Núm. 12, pp. 915-926

2017

  1. Growth hormone-releasing hormone (GHRH) promotes metastatic phenotypes through EGFR/HER2 transactivation in prostate cancer cells

    Molecular and Cellular Endocrinology, Vol. 446, pp. 59-69

  2. Nuevos complejos ciclopentadienilo de titanio (IV) con ligandos quirales amino-oxima. Estudio de su efecto in vitro en cáncer de próstata

    Sextas Jornadas de Jóvenes Investigadores de la Universidad de Alcalá: Ciencias e Ingenierías

  3. Ruleta bioquímica: gamificación inmediata para dinamización de la clase presencial

    Nuevas apuestas educativas [Recurso electrónico]: entre la docencia presencial y la innovación tecnológica

2016

  1. Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer

    Oncotarget, Vol. 7, Núm. 32, pp. 52195-52206

  2. Growth hormone-releasing hormone induced transactivation of epidermal growth factor receptor in human triple-negative breast cancer cells

    Peptides, Vol. 86, pp. 153-161

  3. Novel enantiopure cyclopentadienyl Ti(IV) oximato compounds as potential anticancer agents

    Journal of Inorganic Biochemistry, Vol. 156, pp. 22-34

  4. Transactivación de EGFR y HER2 inducida por la hormona liberadora de la hormona del crecimiento (GHRH) en cáncer de próstata avanzado

    Quintas Jornadas de Jóvenes Investigadores de la Universidad de Alcalá: Ciencias e Ingenierías

2015

  1. Hydrogen Bonding and Anticancer Properties of Water-Soluble Chiral p-Cymene RuII Compounds with Amino-Oxime Ligands

    European Journal of Inorganic Chemistry, Vol. 2015, Núm. 13, pp. 2295-2307